@GLydia
The American society for cancer is a long, long way from a body that is dedicated to eliminating cancer. Because of its 'ownership', in many peoples' opinion it has in effect become, like other similar groups, a body that promotes cancer. All you need to know in order to rationalise that is to see where its funding comes from - pharma. The implications are then:
1. Pharma needs to eliminate effective, safe tobacco alternatives such as e-cigarettes and Snus, in order to protect its NRT sales. If smokers switch to these alternatives, NRTs become irrelevant as there is no need to quit. NRTs are a billion-dollar global market and pharma will do anything to protect it. Pharma's agenda is to make money, it is certainly not to save life. That might happen as a by-product, some or most of the time depending on your opinion - but the main driver is to make money.
The more who switch, the less who die. Preventing the availability of these alternatives kills, and there are 25 years of data from Sweden that prove it - Sweden has the lowest male cancer death rate in Europe. We might say that it has the lowest rate in the developed world, which would almost certainly be true, but some 'developed' countries have imperfect reporting that makes their cancer death stats look better than they are, since they don't really know who died from what.
2. The most profitable drugs may also be dangerous but that is simply unfortunate, it will not result in them being removed from the market. You could probably make up a table of drugs with their: cost in money / deaths due to it / real value in human terms; and Chantix would be right at the top as the most expensive, dangerous, useless drug out there. There is no need for it whatsoever since if you don't want people to die from smoking or kill others with their smoke, then put them on an e-cigarette and/or Snus - you have at least a 75% chance of them succeeding in switching if they are well-mentored (as against a less than 10% chance of success with NRTs), and their risk of death is then going to be about 0.3 on the scale to 100, according to the research. In other words, if they take up an e-cig/Snus they live, if they take Chantix there is a significant risk of death due to heart attack, suicide, or return to smoking. Plus the risk they may kill their family. But remember: Chantix is very profitable for pharma.
3. There is also a reasonable suspicion that it is not really in the interests of the US health industry to remove cancer or reduce it substantially. Cancer treatment drugs are extremely profitable, and cancer treatment accounts for a substantial proportion of health industry earnings. Therefore we might perhaps keep in mind that there is a subtle pressure everywhere, and not just in the US, to maintain the status quo. If cancer disappeared tomorrow, for example, the repercussions would be immense, not just for the industry, but possibly for the economy as a whole.
It's a gravy train, or the status quo, depending on how you look at it. There is very strong financial pressure for pharma to maintain the status quo and they are doing everything in their power to keep it so. Their agents, such as the cancer society, are deeply involved in that work. The fact that the end result is the maintenance of the current cancer death rate, not its reduction, seems to have escaped a lot of people. Smoking is by far the largest cause of cancer; cancer deaths from smoking will be totally eliminated by switching to e-cigarettes; the cancer society is helping pharma to try and stop e-cigarettes. The cancer society is promoting cancer.
The tobacco industry has become much closer to the pharma industry of late, since their objectives are substantially similar. There is no question of those objectives being mutually exclusive, in fact they are virtually the same. Perhaps this is why some tobacco and pharma corporations have the same ownership. It's very good business for both: people smoke, they try to quit, they take the NRTs, they fail and return to smoking, ad infinitum. It works well for both sides. And when they get ill, pharma supplies the heavyweight treatment drugs. Everybody wins. It's kind of like a food company owning farms, it just makes sense.
So people who work for pharma are also working for tobacco, and there is plenty of crossover. The cancer society wouldn't gain if cancer disappeared tomorrow, after all. Their incredible salaries would vaporise and there's no other gravy train around that could substitute on that sort of scale.